• SN-38 Inhibits FUBP1–FUSE Binding: Mechanistic Insights for

  2026-04-25

  This study identifies 7-Ethyl-10-hydroxycamptothecin (SN-38) and camptothecin as inhibitors of the oncoprotein FUBP1’s interaction with its DNA target FUSE, revealing an additional molecular mechanism beyond topoisomerase I inhibition. The findings provide a rationale for targeting FUBP1-regulated transcription in advanced cancer models, with implications for optimizing apoptosis induction strategies.

• TPCA-1: Precision IKK-2 Inhibitor Workflows in Inflammation

  2026-04-24

  TPCA-1 empowers inflammation and cell death researchers with benchmarked, highly selective IKK-2 inhibition—enabling advanced dissection of the NF-κB pathway and cytokine regulation. This guide delivers protocol-centric, troubleshooting-rich strategies for maximizing reproducibility and translational insight with TPCA-1, integrating the latest mechanistic breakthroughs and comparative context.

• SAR405: Precision Vps34 Inhibitor for Autophagy Modulation

  2026-04-24

  SAR405 empowers researchers to dissect autophagy and vesicle trafficking with nanomolar precision, offering exceptional specificity for Vps34 without off-target effects. This guide details optimized workflows, troubleshooting strategies, and integrates new AMPK-ULK1 insights to elevate experimental design in cancer, neurodegeneration, and lysosome research.

• Itraconazole in Translational Candida Research: Mechanisms a

  2026-04-23

  Explore the mechanistic rationale and translational strategy for deploying itraconazole, a triazole antifungal agent, in advanced Candida biofilm and drug resistance studies. This article provides protocol guidance, analysis of recent breakthroughs in autophagy-related resistance, and positions APExBIO's itraconazole as a precision tool for experimental and preclinical workflows.

• EZ Cap™ Firefly Luciferase mRNA: Precision Reporter for mRNA

  2026-04-23

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure delivers high sensitivity and reproducibility for gene regulation and in vivo imaging workflows. Leveraging advanced capping and poly(A) design, it unlocks superior translation efficiency and robust data, even in challenging assay conditions.

• Bromodomain Inhibitor, (+)-JQ1: Applied Workflows in Cancer

  2026-04-22

  Bromodomain Inhibitor, (+)-JQ1 unlocks advanced, reproducible epigenetic modulation for apoptosis assays, inflammation control, and non-hormonal male contraception. This guide translates cutting-edge systems biology insights into practical protocols and troubleshooting for maximizing BET bromodomain inhibitor performance across translational research domains.

• AO/PI Double Staining Kit: Precision Cell Viability Assays

  2026-04-22

  The AO/PI Double Staining Kit empowers researchers to distinguish viable, apoptotic, and necrotic cells in a single, rapid workflow. Its dual-dye approach streamlines apoptosis and necrosis detection, supporting reproducible, high-fidelity cell viability assays across diverse experimental settings.

• Applied Strategies for MOG (35-55) in Autoimmune Encephalomy

  2026-04-21

  Leverage the myelin oligodendrocyte glycoprotein peptide MOG (35-55) for reproducible and mechanistically robust models of multiple sclerosis. This guide demystifies experimental workflows, troubleshooting, and the latest assay innovations—empowering your neuroinflammation research with evidence-backed protocols.

• Dual-Action Inhibitors Accelerate p38α MAPK Dephosphorylatio

  2026-04-21

  The referenced study uncovers how certain kinase inhibitors not only block p38α MAPK activity but also promote its dephosphorylation by stabilizing a distinct activation loop conformation. This dual-action mechanism has significant implications for designing more precise and potent inhibitors in inflammatory signaling and myelodysplastic syndromes research.

• Ciprofloxacin: Advanced Insights for Resistance Transmission

  2026-04-20

  Explore the nuanced role of Ciprofloxacin in fluoroquinolone antibiotic research, with a special focus on plasmid-mediated resistance dynamics and assay design. This article offers a deeper analysis of transmission models and practical parameters for advanced laboratory applications.

• Annexin V-APC/7-AAD Apoptosis Kit: Precision in Cell Death D

  2026-04-20

  The Annexin V-APC/7-AAD Apoptosis Kit streamlines apoptosis and necrosis detection with a rapid, one-step protocol, enabling high-throughput flow cytometry. Its dual-color strategy empowers researchers to dissect cell death mechanisms with clarity, supporting advanced immuno-oncology and translational research.

• Bismuth Subsalicylate: Practical Workflows for GI Research

  2026-04-19

  Bismuth Subsalicylate (SKU A8382) addresses technical challenges in gastrointestinal disorder and inflammation pathway research by serving as a high-purity, non-steroidal inhibitor of prostaglandin G/H synthase 1/2. It is most appropriate for protocols investigating diarrhea, upset stomach, or inflammation mechanisms, but should not be used for diagnostic or therapeutic purposes.

• Phosbind Acrylamide: Elevating Phosphorylation Analysis in T

  2026-04-18

  Explore the mechanistic and strategic power of Phos binding reagent (Phosbind) acrylamide for high-resolution, antibody-free protein phosphorylation analysis. This article dissects its transformative impact on circadian biology and neural signaling, contextualizes its use within the WNK3-PER1 axis, and offers actionable guidance for translational researchers.

• Translating DNA Damage Biomarkers: γH2AX for Precision Oncol

  2026-04-17

  This thought-leadership article explores the mechanistic and translational significance of the γH2AX DNA Damage Detection Kit (Mouse mAb/Red) in the evolving landscape of DNA damage and repair research. By integrating recent advances in radiosensitizer-enabled FLASH-RT, protocol optimization, and benchmarking against current genotoxicity assessment workflows, the discussion provides actionable insights for translational researchers aiming to bridge experimental rigor with clinical relevance.

• 7-Ethyl-10-hydroxycamptothecin in Advanced Colon Cancer Assa

  2026-04-16

  7-Ethyl-10-hydroxycamptothecin (SN-38) sets a benchmark for apoptosis induction and S-phase/G2 phase arrest in metastatic colon cancer models. This guide delivers actionable workflows, data-backed protocol parameters, and troubleshooting strategies to optimize reproducibility using high-purity APExBIO reagent.

16124 records 1/1075 page Next 12345 下5页 Last page